Allon Therapeutics Inc NPCUF:Grey Market

RT Quote | Exchange | USD
Last | undefined
0.00UNCH (UNCH)
52 week range
0.00 - 0.03
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.03
  • 52 Week High Date10/12/21
  • 52 Week Low0.00
  • 52 Week Low Date10/12/21

Key Stats

  • Market Cap-
  • Shares Out141.10M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.03
  • 52 Week High Date10/12/21
  • 52 Week Low0.00
  • 52 Week Low Date10/12/21
  • Market Cap-
  • Shares Out141.10M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-6.559M
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Allon Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is...
James Miller Ph.D.
Independent Chairman of the Board
Gordon McCauley
President, Chief Executive Officer, Director
Matthew Carlyle
Chief Financial Officer, Vice President - Finance, Secretary
Alistair Stewart
Vice President - Commercial Research
Bruce Morimoto
Vice President - Drug Development
Address
1168 Hamilton St Suite 506
Vancouver, BC
V6B 2S2
Canada